Paper11451663
Helical peptide models for protein glycation: proximity effects in catalysis of the Amadori rearrangement.
Venkatraman J and 2 others. Chem Biol, 2001. Cited by 58 papers, by iCite.
Cite this record
ConductScience Library. Helical peptide models for protein glycation: proximity effects in catalysis of the Amadori rearrangement. Papers, record 11451663. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11451663
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Helical peptide models for protein glycation: proximity effects in catalysis of the Amadori rearrangement.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Models, Molecular | Major topic |
| Peptides | Major topic |
| Aspartic Acid | |
| Catalysis | |
| Glucose | |
| Glycosylation | |
| Kinetics | |
| Protein Structure, Secondary | |
| Spectrometry, Mass, Electrospray Ionization |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 58 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41944358 | Deamidation Promotes AGE-Modifications in Human Lens γS-Crystallin. | Biochemistry | 2026 | https://conductscience.org/library/papers/41944358 | PubMed |
| 40827554 | Predictable Modulation of a Spontaneous Post-translational Modification in Living Cells. | Angew Chem Int Ed Engl | 2025 | https://conductscience.org/library/papers/40827554 | PubMed |
| 39152175 | Region-selective and site-specific glycation of influenza proteins surrounding the viral envelope membrane. | Sci Rep | 2024 | https://conductscience.org/library/papers/39152175 | PubMed |
| 38942948 | The chemical language of protein glycation. | Nat Chem Biol | 2025 | https://conductscience.org/library/papers/38942948 | PubMed |
| 37722607 | Glyoxalase I is a novel target for the prevention of metabolic derangement. | Pharmacol Ther | 2023 | https://conductscience.org/library/papers/37722607 | PubMed |
| 35040751 | In silico prediction of post-translational modifications in therapeutic antibodies. | MAbs | 2022 | https://conductscience.org/library/papers/35040751 | PubMed |
| 34168180 | Molecular characterization of sequence-driven peptide glycation. | Sci Rep | 2021 | https://conductscience.org/library/papers/34168180 | PubMed |
| 34083524 | Synergistic sequence contributions bias glycation outcomes. | Nat Commun | 2021 | https://conductscience.org/library/papers/34083524 | PubMed |
| 33466626 | The Taming of Nuclear Factor Erythroid-2-Related Factor-2 (Nrf2) Deglycation by Fructosamine-3-Kinase (FN3K)-Inhibitors-A Novel Strategy to Combat Cancers. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33466626 | PubMed |
| 32486308 | Protein Glycation in Plants-An Under-Researched Field with Much Still to Discover. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32486308 | PubMed |
| 31398338 | The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-Kinase. | Cell | 2019 | https://conductscience.org/library/papers/31398338 | PubMed |
| 31073893 | Comprehensive Analysis of Protein Glycation Reveals Its Potential Impacts on Protein Degradation and Gene Expression in Human Cells. | J Am Soc Mass Spectrom | 2019 | https://conductscience.org/library/papers/31073893 | PubMed |
| 29231845 | Maillard Proteomics: Opening New Pages. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/29231845 | PubMed |
| 29099805 | Glypre: In Silico Prediction of Protein Glycation Sites by Fusing Multiple Features and Support Vector Machine. | Molecules | 2017 | https://conductscience.org/library/papers/29099805 | PubMed |
| 27438287 | Mass spectrometric determination of early and advanced glycation in biology. | Glycoconj J | 2016 | https://conductscience.org/library/papers/27438287 | PubMed |
| 27276998 | Elevation of brain glucose and polyol-pathway intermediates with accompanying brain-copper deficiency in patients with Alzheimer's disease: metabolic basis for dementia. | Sci Rep | 2016 | https://conductscience.org/library/papers/27276998 | PubMed |
| 26933035 | Plasma Proteins Modified by Advanced Glycation End Products (AGEs) Reveal Site-specific Susceptibilities to Glycemic Control in Patients with Type 2 Diabetes. | J Biol Chem | 2016 | https://conductscience.org/library/papers/26933035 | PubMed |
| 26435215 | Site specific modification of the human plasma proteome by methylglyoxal. | Toxicol Appl Pharmacol | 2015 | https://conductscience.org/library/papers/26435215 | PubMed |
| 26030340 | A chemical and computational approach to comprehensive glycation characterization on antibodies. | MAbs | 2015 | https://conductscience.org/library/papers/26030340 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11451663
GET https://conductscience.org/api/papers/v1/11451663/authors